# GLP-1 Users Exercise Less, Despite Weight Loss Drugs' Benefits
People taking GLP-1 receptor agonists like Ozempic and Wegovy exercise less frequently than those not using these medications, new research shows. The finding raises concerns about long-term health outcomes, even as the drugs deliver rapid weight loss.
GLP-1 drugs work by slowing digestion and reducing appetite, allowing users to feel full faster and eat less. Millions of people now use them for weight management and diabetes control. However, the appetite suppression may inadvertently reduce the motivation to exercise, creating a problematic pattern.
The research examined activity levels among GLP-1 users and found they engage in fewer workouts than comparable groups. This matters because exercise provides benefits beyond weight loss. Physical activity strengthens the cardiovascular system, improves bone density, enhances mental health, and reduces disease risk independent of weight alone.
Exercise also helps preserve muscle mass during weight loss, something many GLP-1 users don't naturally prioritize. When people lose weight primarily through reduced eating without resistance training, they risk losing muscle along with fat. This can slow metabolism and make weight regain easier long-term.
Doctors and patients using these medications should recognize this behavioral shift. The drugs aren't a complete replacement for exercise, they're a tool that works best alongside movement. Users may need deliberate strategies to maintain physical activity, including setting specific exercise goals, finding activities they enjoy, or working with trainers.
The takeaway for people considering or currently using GLP-1 medications: weight loss from the medication creates an opportunity to build sustainable habits, including regular exercise. Without intentional focus on movement, users may find themselves dependent solely on medication for weight management, missing out on the broader health gains that come from physical activity. Combining medication with exercise produces better long-term outcomes than medication alone.